Molgramostim Nebulizer Solution Expanded Access Program Protocol
- Status
- AVAILABLE
- Phase
- N/A
Clinical Trials Related to Savara Inc.
Related studies linked through entity extraction aliases.
Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection
- Status
- TERMINATED
- Phase
- PHASE2
Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis
- Status
- TERMINATED
- Phase
- PHASE3
Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) Infection
- Status
- COMPLETED
- Phase
- PHASE2
AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis
- Status
- COMPLETED
- Phase
- PHASE2
Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients
- Status
- COMPLETED
- Phase
- PHASE2
Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics
- Status
- COMPLETED
- Phase
- PHASE1